Ab Magnitude Ventures Group
Overview
Ab Magnitude Ventures Group is a venture capital firm that invests in companies operating in the healthcare, consumer products, consumer services, and information technology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Odyssey Therapeutics | Sep 2025 | Series D | Co-investor |
| ArrePath | Jun 2025 | VC Round | Co-investor |
| Myrobalan Therapeutics | Jan 2024 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Ab Magnitude Ventures Group based?
Ab Magnitude Ventures Group is headquartered in Cambridge, Massachusetts, United States.
When was Ab Magnitude Ventures Group founded?
Ab Magnitude Ventures Group was founded in 2021.
How many portfolio companies does Ab Magnitude Ventures Group have?
Ab Magnitude Ventures Group has 4 portfolio companies in Caplight's dataset.
What are some companies in Ab Magnitude Ventures Group's portfolio?
Portfolio companies visible on Caplight include Odyssey Therapeutics, ArrePath, Myrobalan Therapeutics.
What was Ab Magnitude Ventures Group's most recent investment shown here?
Ab Magnitude Ventures Group's most recent investment in this portfolio sample was in Odyssey Therapeutics in 2025.
What sectors does Ab Magnitude Ventures Group focus on?
Ab Magnitude Ventures Group focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Ab Magnitude Ventures Group focus on?
Ab Magnitude Ventures Group typically invests at the Early stage.
What is Ab Magnitude Ventures Group's AUM?
Ab Magnitude Ventures Group's assets under management are estimated between $0.0 and $50.0M.